The Patent Finder

Terms ending in 2029

Purdue Pharma L.P.

Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,084,612Proline Analogs as Ligands for Cannabinoid Receptors
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 8,181,772Dispenser with Corner Latches
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 8,298,579Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 8,637,073Treatment of Dependence Withdrawal
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 9,149,436Pharmaceutical product comprising a sequestered agent
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 8,476,271Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators
In force
 · High confidence
Purdue Pharma L.P.In forceHigh confidence
US 9,145,408Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators
In force
 · Medium confidence
Purdue Pharma L.P.In forceMedium confidence
US 9,890,164Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators
In force
 · Medium confidence
Purdue Pharma L.P.In forceMedium confidence
US 10,519,1569'-AZA[3,9'-BI(BICYCLO[3.3.1]NONAN)]-3'-ONE and Preparation Thereof
In force
 · Medium confidence
Purdue Pharma L.P.In forceMedium confidence
US 11,111,246Pharmaceutical Salts of Substituted-Quinoxaline-Type Bridged-Piperidine Compounds
In force
 · Medium confidence
Purdue Pharma L.P.In forceMedium confidence
12 more term ends in 2029 · Pro
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
Upgrade to Pro
21 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited